Laphal   Report issue

For profit Phase 3
Founded: Allauch France (1970)
Status: Acquired by Zambon (2003)

Organization Overview

First Clinical Trial
2003
NCT01070862
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Myeloma (Phase 3)

Neoplasms, Plasma Cell (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 6